NeuroSense Therapeutics (NRSN) Earnings Date & Reports
A.I. Advisor
published Earnings
NRSN is expected to report earnings to fall 45.71% to -18 cents per share on August 28
Q2'24
Est.
$-0.19
Q1'24
Missed
by $0.14
Q4'23
Beat
by $0.02
Q3'23
Beat
by $0.31
Q2'23
Beat
by $0.03
The last earnings report on June 24 showed earnings per share of -34 cents, missing the estimate of -20 cents. With 64.44K shares outstanding, the current market capitalization sits at 24.92M.